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Abstract 
Background: To study the prevalence of chronic 
kidney disease in family members of dialysis 
patients 
Methods: In this cross-sectional observational 
study relatives of incident dialysis patient were 
enrolled. Family members of patients of all ages 
with history of diabetes mellitus, hypertension, 
family history of chronic kidney disease, chronic 
pyelonephritis and autoimmune diseases were 
included. Relatives already on renal replacement 
therapy, Hepatitis B and C, HIV reactive patients 
and with chronic heart and liver failure, chronic 
infections and septicemia patients were excluded . 
Results: Out of these 200 participants, majority 
(72%) were male. Minimum age of the study 
population was 18 years and maximum age was 66 
years. Mean age was 35.5 ± 9.93 years.  Frequency of 
risk factors in study population showed that out of 
200 participants 15% had hypertension, 6% had 
diabetes, 2.5% had renal stone disease and 74% 
participants did not have any risk factor. Blood 
pressure was normal in 83% participants. Blood 
glucose was normal in 92.5%. 
Conclusion: Screening of the family members of 
ESRD patients is important for the prevention of 
kidney disease in other family members.  
Key Words: Family members,Chronic kidney 
disease,Dialysis patients 
Introduction 
Chronic Kidney Disease (CKD) is a worldwide public 
health problem.1 The declaration of World Kidney Day 
to be observed annually beginning in March 2006 
sends a clear message to the public, government health 
officials, physicians, allied health professionals, 
patients, and families that ‘CKD is common, harmful, 
and treatable. 2  
 Chronic kidney disease (CKD) is receiving increased 
public attention, with early prevalence estimates at 
11%  and more recent estimates showing that 13% of 
the US population has some evidence of kidney 
damage.3,4  More than 20 million Americans aged 20 
and older may have CKD, based on a decreased 
glomerular filtration   rate (GFR), a measure of kidney 
function. Although CKD is common, many Americans 
with the key risk factors—diabetes and high blood 
pressure—do not know they are at risk.  In addition,  
the rising rates of diabetes and obesity will continue to 
fuel its growth, as both conditions increase the risk of 
developing CKD and speed its progression. A recent 
national survey in China  indicates that the prevalence 
of CKD in China is 10.8%.5 In addition to kidney 
failure, other serious complications— particularly 
cardiovascular disease (CVD)—are associated   with 
CKD.  Other complications include anemia, 
malnutrition, bone disease, and depression  
The exact prevalence of chronic kidney disease in 
Pakistan is not clear in the absence of regular national 
registry data and provided only by small observation 
series or reports from personal experience, and the 
quality of data is quite uneven. CKD is defined as 
presence of kidney damage or glomerular filtration 
rate less than 60ml/min/1.73msq for 3 or longer, 
irrespective of cause.6-8 CKD and ESRD impose a 
tremendous public health burden, costing the U.S. 
health care system billions  of dollars.  In 2006, costs 
for Medicare patients with CKD exceeded $49 billion, 
accounting for nearly  one-quarter of general Medicare 
costs (USRDS, 2008). Medicare spending for ESRD 
reached $22.7 billion during the same year (USRDS, 
2008).  By 2020, Medicare ESRD costs are expected to 
reach  $55.6 billion (USRDS, 2007).  Survival, Mortality 
and Causes of Death in ESRD Patients  Despite 
advances in dialysis and transplantation, the prognosis 
of kidney failure remains bleak. The USRDS reported 
more than 60000 deaths of patients with ESRD, and an 
annual mortality rate of dialysis patients in excess of 
20%. Expected remaining lifetime of patients treated 
by dialysis were shorter than the age matched general 
population, varying (depending on race and gender) 
from 7.1 to 11.5 years for patients aged 40 to 44 years, 
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and from 2.7 to 3.9 years for patients aged 60 to 64 
years. 9-11 
Therapeutic interventions at earlier stages of chronic 
kidney disease are effective in slowing the progression 
of chronic kidney disease The major therapeutic 
strategies that have been tested include strict blood 
glucose control in diabetes, strict blood pressure 
control, angiotensin-converting enzyme (ACE) 
inhibitors and angiotensin-receptor blockers, and 
dietary protein restriction. Patients with CKD have a 
large number of comorbid conditions. Comorbidity is 
defined as conditions other than the primary disease 
(in this case, chronic kidney disease). Screening and 
early detection of kidney disease has the aim not only 
to prevent kidney damage but also to prevent 
comorbidities associated with chronic kidney disease 
Patients and Methods 
This cross sectional observational study was 
conducted at Nephrology Department, Pakistan 
Institute of Medical Sciences from January 2014 to 
January 2015.All relatives of incident dialysis patients 
were taken for the study. Documentation of existing 
standards of care for chronic diseases associated with 
renal disease was done and institution of disease 
management program that facilitate the systematic 
management of patient with chronic diseases that lead 
to end stage renal disease. Randomized non-biased 
sampling of patients admitted or consulted the 
Nephrology department of Pakistan Institute of 
Medical Sciences was done. Patients of all ages with 
history of diabetes mellitus, hypertension, family 
history of chronic kidney disease, chronic 
pyelonephritis and autoimmune diseases were 
included. Patients with renal replacement therapy, 
Hepatitis B and C, HIV, those with chronic heart and 
liver failure and finally patients with chronic infections 
and septicaemic patients were excluded from study. 
Results 
Total 200 family members of the patients on 
maintenance dialysis for ESRD were included after 
taking the consent and fulfilling the inclusion and 
exclusion criteria. Out of these 200 participant majority 
(72%) were male . Minimum age of the study 
population was 18 years and maximum age was 66 
years. Mean age is 35.5 ± 9.93 years. Donors’ breakup 
revealed that  112 (56%) were sons, followed by 
36(18%) daughters and 24(12%) brothers. 
Hypertension (15%) was the commonest risk factor 
found (Table 1). Blood pressure was normal in 83%. 
Blood glucose was found to be normal in 92.5% and 
increased in 7.5% participants (Table 2).  
Majority (85.5%) of the participants   did not have any 
urinary protein, 21(10.5%) had 1+ protein, 6(3%) had 
2+ protein, and 2 (1%) participants had 3+ urinary 
protein . Similarly 178 (89%) participants did not have 
urinary glucose, 10(5%) had 1+ glucose, 7(3.5%) had 
2+ glucose, 4(2%) had 3+ glucose and one (0.5%) had 
4+ urinary glucose. Lipid profile was normal in 73.5%. 
Minimum Hb was 8, maximum was 18, mean was 
12.12 ±2.09 g/dl. (Table 2).  On ultrasound  kidney 
sizes were normal in 79%. 
Table 1:Frequency of risk factors 
Risk factors Number Percentage 
Hypertension 30 15% 
Diabetes Mellitus(DM) 12 6% 
Coronary artery disease 2 1% 
Stone disease 5 2.5% 
Hypertension+DM 3 1.5% 
No risk factor 148 74% 
Table 2:Descriptive statistics of the study 
population (n=200) 
Variables Range Min Max Mean SD 
Age  48 18 66 35.95 9.931 
Weight(Kg) 67  42 109 72.67 15.34 
Blood 
glucose(mg
/dl) 
232  54 234 106.21 31.41 
Urine pH 3.0 5.0 8.0 6.007 .7933 
RBC in 
Urine 
62 0 62 2.37 6.937 
WBC in 
Urine 
43 0 43 1.88 4.440 
Serum 
Creatinine 
(mg/dl) 
6.68 .32 3.20 .8176 .4342 
Haemoglobin 97.0 8.0 18.0 12.12 2.090 
Serum 
Phosphorus 
2.18 3.00 5.18 3.7380 .3880 
Serum 
Calcium 8.9 7 9.5 8.44 .3991 
Discussion 
Chronic kidney disease (CKD) is increasingly 
recognized as a global public health problem. The 
declaration of World Kidney Day to be observed 
annually beginning in March 2006 sends a clear 
message to the public, government health officials, 
physicians, allied health professionals, patients, and 
families that ‘CKD is common, harmful, and 
treatable.12 The exact prevalence of chronic kidney 
disease in Pakistan is not clear in the absence of 
regular national registry data and provided only by 
small observation series or reports from personal 
experience, and the quality of data is quite uneven.  
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CKD is defined as presence of kidney damage or 
glomerular filtration rate less than 60ml/min per 1.73 
msq for 3 or more months, irrespective of cause.13 We 
included 200 relatives of the patients with ESRD and 
on dialysis. Though this number is not much large as 
compared to international screening analysis, it still 
gives us direction toward the future strategies. Same 
cross-sectional survey of screening to identify CKD 
among family members of ESRD patients was 
conducted at different community dialysis centers in 
Georgia.14 Family members of ESRD patients were 
recruited for CKD screening. A medical history, 
measurements of BP, serum glucose, hemoglobin (Hb), 
serum creatinine, and urinalysis were obtained at 
community screening sites. Of 221 family members 
screened between 1999 and 2001 in Georgia, 13.9% had 
an estimated creatinine clearance (Ccr) _60 ml/min. 
Proteinuria of 1+ or more was found on urinalysis in 
9.9%. In our analysis proteinuria was significantly 
present and was 1+ in 10% of the patients. However in 
another screening survey, out of 84 participants, 26% 
of these had proteinuria.15-17A multicenter study in 
China shows presence of CKD is different between 
first-degree relatives and spouses of CKD patients.18 
Hypertension was present in 15% of our study 
population, where as it was present with much higher 
frequency in a cross-sectional survey in Georgia where 
58% of the study participants were hypertensive, some 
of which were getting treatment for hypertension and 
some unaware of their disease. 14 Where as in other 
surveys, 21.9% of the family members of the ESRD 
patients had hypertension, and these results were 
comparable with our study results. 
In present study, 7.5 % of the participants had 
impaired blood glucose and 92.5% of the participants 
had normal blood glucose. When we compare these 
results with international data, it was found that in 
Georgia survey, 18.6% of the study population had 
increased blood glucose.8 Where as in other survey 
18.1 % of the participants had impaired blood glucose 
The study by Iseki in the Okinawa region of Japan also 
demonstrated that proteinuria and high serum 
creatinine level are two valuable prognostic factors for 
end-stage renal disease.  18 Out of 200 participants ,  
8% of the participants had increased serum creatinine. 
Conclusion 
1. Screening of the family members of ESRD patients 
is important for the prevention of kidney disease 
in other family members.  
2. In present study 13 % of the patients had 
proteinuria, 15 % of the patients had increased 
blood pressure, 7.5 % of the participants had 
impaired blood glucose. 
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